Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 58 out of 100. Clinical safety

Topic: Risk, prevention and care in population studies

Plain-language summary

Outcomes of interest were duration of delirium, health-related quality of life, delirium severity, cognitive function, mortality in the ICU, ICU length of stay, hospital length of stay and adverse events. RISK OF BIAS: We used Cochrane's risk of bias 2 tool (RoB 2) for assessing RCTs. SYNTHESIS Exercise therapy compared to no intervention or usual care In adults with a diagnosis of delirium after admission to the ICU, exercise therapy may reduce the duration of delirium (MD -1.07 days, 95% CI -1.75 to -0.39; 4 studies, 121 participants; low-certainty evidence). Additionally, exercise therapy may result in no adverse events in adults with a diagnosis of delirium after admission to the ICU, as no adverse events were reported in either group (2 studies, 90 participants; low-certainty evidence). Exercise therapy probably reduces the ICU length of stay in adults with a diagnosis of delirium after admission to the ICU (MD -2.24 days, 95% CI -3.63 to -0.85; 3 studies, 107 participants; moderate-certainty evidence). None of the included studies assessed health-related quality of life or delirium severity for this comparison. The included studies had an overall high risk of bias, or we had some concerns about the risk of bias, for the different evaluated outcomes. Imprecision in the effect estimates was also a concern due to small sample sizes and limited numbers of events. Exercise therapy compared to pharmacological treatment None of the included studies evaluated a comparison between exercise therapy and pharmacological treatment. AUTHORS' In adults with a diagnosis of delirium after admission to the ICU, exercise therapy may reduce the duration of delirium, probably reduces the ICU length of stay, and may result in no adverse events. None of the included studies reported health-related quality of life or delirium severity, and no studies compared exercise therapy to any pharmacological treatment. The certainty of the evidence was low to moderate. We need further studies assessing the effects of exercise therapy on treating delirium in the ICU. These new studies must address the limitations found in the studies included in this review, especially considering larger sample sizes. Future studies should also focus on health-related quality of life, delirium severity, and cognitive function. They must also compare exercise therapy with additional treatment available in the clinical setting, such as highly disseminated pharmacological treatments, and focus on differe

What this study adds

Evidence grade: High

This is a pooled review of 491 participants. This meta-analysis found low-certainty evidence that exercise therapy may reduce the duration of delirium and moderate-certainty evidence that it probably reduces ICU length of stay in adults with delirium after ICU admission. It is about treating delirium in intensive care, not about treating, curing or preventing Alzheimer's disease.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Garegnani, L., Ivaldi, D., Burgos, M. A., Varela, L. B., Menai, S. D., Rico, S., et al. (2025). Exercise therapy for the treatment of delirium in the intensive care unit. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd015830.pub2

Vancouver

Garegnani L, Ivaldi D, Burgos MA, Varela LB, Menai SD, Rico S, et al. Exercise therapy for the treatment of delirium in the intensive care unit. Cochrane Database of Systematic Reviews. 2025. doi:10.1002/14651858.cd015830.pub2. PMID: 40792601.

BibTeX

@article{garegnani2025-40792601,
  author  = {Garegnani, Luis and Ivaldi, Diego and Burgos, Mariana Andrea and Varela, Lucia B and Menai, Samanta Díaz and Rico, Sabrina and Giménez, María Lucía and Liquitay, Camila Micaela Escobar and others},
  title   = {{Exercise therapy for the treatment of delirium in the intensive care unit}},
  journal = {Cochrane Database of Systematic Reviews},
  year    = {2025},
  doi     = {10.1002/14651858.cd015830.pub2},
  pmid    = {40792601},
  url     = {https://doi.org/10.1002/14651858.cd015830.pub2}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

This meta-analysis found low-certainty evidence that exercise therapy may reduce the duration of delirium and moderate-certainty evidence that it probably reduces ICU length of stay in adults with delirium after ICU admission. It is about treating delirium in intensive care, not about treating, curing or preventing Alzheimer's disease.

Study details

How this study scored 58/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 3 of 4; Study design 12 of 12; Strength of evidence 5 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 2 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 1 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 58 of 100.58 of 100 points earned42 not earned

Published in a leading specialty journal, and it is a meta-analysis pooling many studies. Scored zero for effect reported because the record does not state it.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (Cochrane Database of Systematic Reviews)
Journal's citation record 3 / 4 Cochrane Database of Systematic Reviews: journal h-index 468 (OpenAlex, 2026-10-29)
Study design 12 / 12 A meta-analysis pooling many studies
Strength of evidence 5 / 5 Rated “high” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 2 / 4 491 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 A review of other studies — randomization is not credited here
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.3 citations a year over 3 year(s) since 2025
Impact for its field and year 1 / 6 Cited 0.8× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Juan Víctor Ariel Franco: h-index 28 (OpenAlex, whole career)
Institution's track record 1 / 3 Heinrich Heine University Düsseldorf: institution h-index 794 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 3 institution(s) in 2 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40792601)
Free to read 2 / 2 Free to read
Total 58 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Clinical safety from nearby years

Also tagged “palliative”

858 studies in the library carry the topic tag “palliative”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 858 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Clinical safety

See all studies in Clinical safety →